Efficacy and Safety of Vernakalant in Recent-Onset Atrial Fibrillation After the European Medicines Agency Approval: Systematic Review and Meta-Analysis

Association of the Ottawa Aggressive Protocol with rapid discharge of emergency department patients with recent-onset atrial fibrillation or flutter

(2016) Ian G. Stiell et al.   Canadian Journal of Emergency Medicine

Intravenous Vernakalant

(2011) Sean T. Duggan et al.   DRUGS

A Randomized Active-Controlled Study Comparing the Efficacy and Safety of Vernakalant to Amiodarone in Recent-Onset Atrial Fibrillation

(2011) A. John Camm et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A multicenter, open-label study of vernakalant for the conversion of atrial fibrillation to sinus rhythm

(2010) Ian G. Stiell et al.   AMERICAN HEART JOURNAL

Usefulness of Vernakalant Hydrochloride Injection for Rapid Conversion of Atrial Fibrillation

(2010) Craig M. Pratt et al.   AMERICAN JOURNAL OF CARDIOLOGY

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPACE

New antiarrhythmic drugs for treatment of atrial fibrillation

(2010) Dobromir Dobrev et al.   LANCET

Vernakalant Hydrochloride for the Rapid Conversion of Atrial Fibrillation After Cardiac Surgery

(2009) Peter R. Kowey et al.   Circulation-Arrhythmia and Electrophysiology

A Prospective, Randomized Trial of an Emergency Department Observation Unit for Acute Onset Atrial Fibrillation

(2008) Wyatt W. Decker et al.   ANNALS OF EMERGENCY MEDICINE

Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation

(2008) Denis Roy et al.   CIRCULATION

Vernakalant – a promising therapy for conversion of recent-onset atrial fibrillation

(2008) Gerald V Naccarelli et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Pharmacokinetics of Novel Atrial-Selective Antiarrhythmic Agent Vernakalant Hydrochloride Injection (RSD1235): Influence of CYP2D6 Expression and Other Factors

(2008) Zhongping L. Mao et al.   JOURNAL OF CLINICAL PHARMACOLOGY